Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 5-(pyrimidin-4-yl)thiazol-2-yl urea derivatives as therapeutic agents

5-(pyrimidin-4-yl)thiazol-2-yl urea derivatives as therapeutic agents

US Patent 11325900 · Granted May 10, 2022

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Derivatives of 4-(imidazo[1,2-a]pyridin-3-yl)-n-(pyridinyl)pyrimidin-2-amine as 2025
Derivatives of 4-(imidazo[1,2-a]pyridin-3-yl)-n-(pyridinyl)pyrimidin-2-amine as 2025
N-(pyridin-2-yl)-4-(thiazol-5-yl)pyrimidin-2-amine derivatives as therapeutic co2024
N-(pyridin-2-yl)-4-(thiazol-5-yl)pyrimidin-2-amine derivatives as therapeutic co2024
N-(pyridin-2-yl)-4-(thiazol-5-yl)pyrimidin-2-amine derivatives as therapeutic co2024
N-(pyridin-2-yl)-4-(thiazol-5-yl)pyrimidin-2-amine derivatives as therapeutic co2024
Tartrate of selective CDK9 inhibitor and crystal form thereof2023
Derivatives of N-cycloalkyl/heterocycloalkyl-4-(imidazo[1,2-a]pyridine)pyrimidin2021
N-(pyridin-2-yl)-4-(thiazol-5-yl)pyrimidin-2-amine derivatives as therapeutic co2019
N-(pyridin-2-yl)-4-(thiazol-5-yl)pyrimidin-2-amine derivatives as therapeutic co2019
Zeolite and redox oxide combined catalyst body2019
Zeolite and redox oxide combined catalyst body2016